Results 151 to 160 of about 9,438 (207)

Bidirectional Mendelian randomization study reveals causal relationships between polymyalgia rheumatica and serum metabolites. [PDF]

Medicine (Baltimore)
Song A, Kang L, Cao S, Wang Y, Li H.
europepmc   +1 more source

When can calcium pyrophosphate deposition disease be considered a polymyalgia rheumatica mimicking disease? [PDF]

Reumatologia
Manzo C, Falsetti P, Castagna A, Isetta M, Conticini E.   +4 more
europepmc   +1 more source

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. [PDF]

Rheumatology (Oxford)
Vermeulen OCB, Brouwer E, Slart RHJA, Sandovici M, Rutgers A, Hilterman TJ, Hiddinga B, Oosting SF, Jalving M, de Heij AH, Knapen DG, Hospers GAP, van der Geest KSM.   +12 more
europepmc   +1 more source

Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. Reply. [PDF]

Rheumatology (Oxford)
van der Geest KSM, Sandovici M, Rutgers A, Brouwer E.   +3 more
europepmc   +1 more source

Are There Definite Disease Subsets in Polymyalgia Rheumatica? Suggestions from a Narrative Review. [PDF]

Healthcare (Basel)
Falsetti P, Manzo C, Isetta M, Placido F, Castagna A, Natale M, Baldi C, Conticini E, Frediani B.   +8 more
europepmc   +1 more source

Patient perspectives on life impact and unmet needs in giant cell arteritis and polymyalgia rheumatica: insights from social media. [PDF]

Rheumatol Adv Pract
Mackie SL, Arun P, Padmanabhan V, Arjona A, Kullman JA.   +4 more
europepmc   +1 more source

Polymyalgia Rheumatica and Giant Cell Arteritis: A Geriatric Perspective. [PDF]

Cureus
Muhammad A, Kakar ZH, Farooq M, Roohani MU, Bibi Z, Elgorashi K, Ahmad S, Ali J, Sami N.   +8 more
europepmc   +1 more source

Evaluation of the Glucocorticoid-Sparing Effect of Adding Methotrexate in Polymyalgia Rheumatica: A Single-Center Retrospective Study. [PDF]

Cureus
Kitai J, Miyake H, Sada RM, Tsugihashi Y, Hatta K.   +4 more
europepmc   +1 more source

Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica. [PDF]

RMD Open
Tanaka Y, Takahashi T, Fukasawa T, Inokuchi S, Uenaka H, Fujita A, Shimamoto K, Sakamoto K.   +7 more
europepmc   +1 more source

Subclinical aortic inflammation in patients with polymyalgia rheumatica. [PDF]

Rheumatology (Oxford)
Kaymakci MS, Berry GJ, Langenfeld HE, Hanson AC, Crowson CS, Bois MC, Schaff HV, Sato Y, Le KC, Koster MJ, Weyand CM, Warrington KJ.   +11 more
europepmc   +1 more source